BioNet News 28 Feb 2025 Infant Responses to Primary Immunization Following Vaccination in Pregnancy With Varying Doses of Recombinant Acellular Pertussis Vaccine Alone or Combined With Tetanus-Diphtheria Pertussis is a highly contagious infectious disease of the respiratory tract caused by Bordetella pertussis. Disease is most severe in young… Pantitra
BioNet News 31 Dec 2024 A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial Pertussis, also known as whooping cough, is an acute respiratory disease caused by Bordetella pertussis, a bacterium that is transmitted between… Pantitra
Biotech News 16 Jul 2024 UKHSA encourages timely vaccination as whooping cough cases rise New data published today by the UK Health Security Agency (UKHSA) shows cases of whooping cough continue to increase with… Pantitra
Biotech News 29 Apr 2024 With whooping cough cases on the rise, do you need a booster vaccine? Cases of pertussis are particularly dangerous for babies, experts warn — here's what to know for all ages As whooping… Pantitra
Biotech News 19 Apr 2024 Whooping Cough Cases Rise Across Europe, Asia And Parts Of U.S. Whooping cough outbreaks are expanding across Europe, Asia and parts of the United States, including Northern California. Since December of last… Pantitra
BioNet News 05 Apr 2022 A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age A phase 2 randomized-controlled safety and immunogenicity trial evaluating different doses of recombinant acellular pertussis vaccine containing genetically-inactivated pertussis toxin… Pantitra
BioNet News 23 Jul 2021 Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines Recombinant pertussis vaccines inducing long-lasting immune responses could help to control the rise in pertussis. We here report on persisting… Pantitra
BioNet News 05 Dec 2020 Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen®) vaccine for immunization of adolescents and adults in Thailand A new generation of recombinant acellular pertussis vaccine containing genetically inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis… Pantitra
